MedTrace Logo

Probiotics Attenuate Postoperative Cognition Decline

NCT04017403 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2022-05-02

No results posted yet for this study

Summary

The aim of this study was to evaluate whether perioperative probiotics can reduce the incidence of postoperative cognitive dysfunction and postoperative delirium.

Conditions

  • Necrosis of Femoral Head
  • Knee Osteoarthritis
  • Fracture of Neck of Femur
  • Lumbar Disc Herniation

Interventions

DRUG

Bifidobacterium triple live capsule

Bifidobacterium triple live capsules, indications for acute and chronic diarrhea and constipation caused by intestinal flora imbalance, can also be used for the treatment of mild to moderate acute diarrhea, chronic diarrhea and indigestion, bloating, and adjuvant treatment of intestinal flora Endotoxemia caused by disorders.

DRUG

Placebos

Placebos were administrated as same as the bifidobacterium live capsule

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • su diansan · RenJi Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-15
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04017403 on ClinicalTrials.gov